Extended-release methylphenidate: A review of the pharmacokinetic profiles of available products

Hina Radia, Medicines Information Pharmacist, London and South East Regional Medicines InformationPublished

This review discusses current NICE recommendations for the use of methylphenidate for the treatment of ADHD and describes the pharmacokinetic differences between the currently available modified-release products available: Concerta XL, Delmosart XL, Equasym XL, Matoride XL, Medikinet XL, Ritalin XL, Xaggitin XL and Xenidate XL.

Attachments